Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefan Lethagen

Showing results (11-20 of 49) with videos related to

Pageof 5
Sort By:
Thrombosis Research|June 15, 2010
Optimizing thrombelastography (TEG) assay conditions to monitor rFVIIa (NovoSeven) therapy in haemophilia A patientsDorthe Viuff, Søren Andersen, Brit B Sørensen, et al.
TH Open : Companion Journal to Thrombosis and Haemostasis|November 4, 2020
Common and Rare Variants in Genes Associated with von Willebrand Factor Level Variation: No Accumulation of Rare Variants in Swedish von Willebrand Disease PatientsEric Manderstedt, Christina Lind-Halldén, Stefan Lethagen, et al.
TH Open : Companion Journal to Thrombosis and Haemostasis|June 29, 2019
Genetic Variation in the von Willebrand Factor Gene in Swedish von Willebrand Disease PatientsEric Manderstedt, Christina Lind-Halldén, Stefan Lethagen, et al.
Journal of Thrombosis and Thrombolysis|January 30, 2007
Menorrhagia and minor bleeding symptoms in women on oral anticoagulationAnders Själander, Britt Friberg, Peter Svensson, et al.
Thrombosis Research|April 27, 2005
Protein C levels can be forecasted by global haemostatic tests in critically ill patients and predict long-term survivalGunnar Nilsson, Jan Astermark, Stefan Lethagen, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|January 31, 2006
Evaluation of a rapid automated assay for analysis of von Willebrand ristocetin cofactor activityKarin Strandberg, Stefan Lethagen, Kerstin Andersson, et al.
Ugeskrift for Laeger|July 15, 2005
[Rational blood component therapy in patients with life-threatening hemorrhage]Pär Ingemar Johansson, Stefan Lethagen, Freddy K Lippert, et al.
Thrombosis and Haemostasis|July 5, 2018
Genetic Variation in the Syntaxin-Binding Protein STXBP5 in Type 1 von Willebrand Disease PatientsChristina Lind-Halldén, Eric Manderstedt, Daniel Carlberg, et al.
Thrombosis and Haemostasis|August 12, 2008
Characterization of a novel mutation in the von Willebrand factor propeptide in a distinct subtype of recessive von Willebrand diseaseElsa Lanke, Ann-Charlotte Kristoffersson, Malou Philips, et al.
Thrombosis Research|March 26, 2004
Mutations within the cyclooxygenase-1 gene in aspirin non-responders with recurrence of strokeAndreas Hillarp, Barbro Palmqvist, Stefan Lethagen, et al.
Pageof 5

Showing results (11-20 of 49) with videos related to

Sort By:
Pageof 5
Thrombosis Research|June 15, 2010
Optimizing thrombelastography (TEG) assay conditions to monitor rFVIIa (NovoSeven) therapy in haemophilia A patientsDorthe Viuff, Søren Andersen, Brit B Sørensen, et al.
TH Open : Companion Journal to Thrombosis and Haemostasis|November 4, 2020
Common and Rare Variants in Genes Associated with von Willebrand Factor Level Variation: No Accumulation of Rare Variants in Swedish von Willebrand Disease PatientsEric Manderstedt, Christina Lind-Halldén, Stefan Lethagen, et al.
TH Open : Companion Journal to Thrombosis and Haemostasis|June 29, 2019
Genetic Variation in the von Willebrand Factor Gene in Swedish von Willebrand Disease PatientsEric Manderstedt, Christina Lind-Halldén, Stefan Lethagen, et al.
Journal of Thrombosis and Thrombolysis|January 30, 2007
Menorrhagia and minor bleeding symptoms in women on oral anticoagulationAnders Själander, Britt Friberg, Peter Svensson, et al.
Thrombosis Research|April 27, 2005
Protein C levels can be forecasted by global haemostatic tests in critically ill patients and predict long-term survivalGunnar Nilsson, Jan Astermark, Stefan Lethagen, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|January 31, 2006
Evaluation of a rapid automated assay for analysis of von Willebrand ristocetin cofactor activityKarin Strandberg, Stefan Lethagen, Kerstin Andersson, et al.
Ugeskrift for Laeger|July 15, 2005
[Rational blood component therapy in patients with life-threatening hemorrhage]Pär Ingemar Johansson, Stefan Lethagen, Freddy K Lippert, et al.
Thrombosis and Haemostasis|July 5, 2018
Genetic Variation in the Syntaxin-Binding Protein STXBP5 in Type 1 von Willebrand Disease PatientsChristina Lind-Halldén, Eric Manderstedt, Daniel Carlberg, et al.
Thrombosis and Haemostasis|August 12, 2008
Characterization of a novel mutation in the von Willebrand factor propeptide in a distinct subtype of recessive von Willebrand diseaseElsa Lanke, Ann-Charlotte Kristoffersson, Malou Philips, et al.
Thrombosis Research|March 26, 2004
Mutations within the cyclooxygenase-1 gene in aspirin non-responders with recurrence of strokeAndreas Hillarp, Barbro Palmqvist, Stefan Lethagen, et al.
Pageof 5